Clinical quality managment (CQM) in rheumatoid arthritis (RA) aims to reduc
e inflammatory activity and pain in the short term, and damage, and consequ
ently disability, in the long term. Within CQM as used in Switzerland rheum
atologists are provided with a measurement feedback system with which they
can regularly follow their patients. Inflammatory activity is measured with
the Disease Activity Score (DAS28) and the Rheumatoid Arthritis Disease Ac
tivity Index questionnaire (RADAI), damage with an X-ray score and disabili
ty with the Stanford Health Assessment Questionnaire (HAQ). Feedback is use
d to optimize therapy, which in the short term allows the activity of the i
nflammatory process to be adjusted or 'titrated'. In the long term, the the
rapy result for the individual patient is monitored by the course of disabi
lity and damage. In this paper we present a series of cases to illustrate t
he usefulness of the CQM system in the management of individual RA patients
. CQM in RA may be helpful when making decisions about adjustment of treatm
ent, and to document and communicate these decisions based on quantitative
data.